封面
市場調查報告書
商品編碼
1859466

新冠病毒檢測套組市場規模、佔有率、成長分析(依產品類型、檢體/樣本類型、最終用戶、檢測模式、地區分類)-2025-2032年產業預測

COVID Testing Kit Market Size, Share, and Growth Analysis, By Product Type, By Specimen / Sample Type, By End-User, By Mode of Testing, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 191 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球新冠病毒檢測套組市場預計到 2023 年將達到 801 億美元,從 2024 年的 861.9 億美元成長到 2032 年的 1,548.6 億美元,在預測期(2025-2032 年)內複合年成長率為 7.6%。

全球新冠病毒檢測套組市場正因數位醫療解決方案和電子商務的興起而發生變革,其中,自測檢測套組因其便利性而日益普及,尤其是在都市區。鼻拭子和唾液檢測也因其易用性而廣受歡迎。業內公司正致力於研發能夠檢測多種呼吸道病毒的多重診斷技術,而衛生部門也因其成本效益而對其需求不斷成長。此外,人工智慧技術的應用提高了檢測準確性並縮短了檢測週期,從而增強了消費者對居家檢測和實驗室檢測的信心。儘管面臨市場飽和和成本壓力等挑戰,但對新冠病毒檢測套組的需求仍然強勁,隨著行動醫療醫療和診斷技術的不斷創新,該市場展現出巨大的成長潛力。

全球新冠病毒檢測套組市場促進因素

全球新冠病毒檢測套組市場的主要促進因素之一是,隨著世界持續應對新冠疫情及其變種,對快速、準確的診斷工具的需求不斷成長。人們日益認知到早期檢測在控制疫情的重要性,促使醫療機構、政府和個人將檢測列為優先事項。家用檢測套組的興起提供了便利性和可及性,滿足了更廣泛人群的需求。此外,檢測技術的不斷進步,例如高靈敏度和高特異性檢測方法的開發,進一步推動了市場成長,並滿足了全球醫療保健系統的多樣化需求。

全球新冠病毒檢測套組市場面臨的限制因素

全球新冠病毒檢測套組市場面臨許多限制因素,包括監管挑戰和各地區標準不一。檢測套組的核准流程漫長而複雜,可能導致產品上市延遲。此外,品管和準確性標準的差異會削弱公眾對檢測方案的信任,阻礙其廣泛應用。這些因素,加上其他診斷方法的出現和政府優先事項的轉變,也可能分散檢測項目的資金和關注。因此,製造商必須應對複雜的合規和市場接受度挑戰,這影響了其成長潛力。

全球新冠病毒檢測套組市場趨勢

全球新冠病毒檢測套組市場正經歷著向自我檢測和居家診斷的重大轉變,這主要得益於消費者對分散式醫療解決方案日益成長的需求。隨著監管核准的不斷擴大,基於唾液的自我檢測抗原試劑套件因其易用性、價格實惠以及減少就醫次數等優勢,尤其是在感染疾病再次爆發期間,正受到消費者的青睞。這一趨勢反映了消費者在醫療保健管理方面對便利性和自主性的日益偏好,顯著影響著市場動態並推動產品研發的創新。對快速可靠檢測方式的日益重視正在改變新冠病毒檢測格局,增強市場的韌性和適應性。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場概覽
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2024)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 技術評估
  • 監管環境
  • 客戶和購買標準分析
  • 原料分析

新冠病毒檢測套組市場規模(依產品類型分類)及複合年成長率(2025-2032 年)

  • 市場概覽
  • RT-PCR檢測試劑套件
  • 免疫檢測測定試紙/試劑盒
  • 基於CRISPR的分子診斷套件
  • 其他分子檢測套件

新冠病毒檢測套組市場規模(依檢體/樣本類型分類)及複合年成長率(2025-2032 年)

  • 市場概覽
  • 鼻咽拭子
  • 口咽拭子
  • 鼻拭子
  • 唾液樣本
  • 血液/指尖採血

新冠病毒檢測套組市場規模(依最終用戶分類)及複合年成長率(2025-2032 年)

  • 市場概覽
  • 醫院和診所
  • 診斷實驗室
  • 居家護理/自我檢查
  • 公共衛生機構
  • 其他

新冠病毒檢測套組市場規模(依檢測模式分類)及複合年成長率(2025-2032 年)

  • 市場概覽
  • 集中式實驗室檢測(非即時檢測)
  • 照護現場偵測 (POC)
  • 商店(OTC)自測

新冠病毒檢測套組市場規模及複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2024 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2024 年)
  • 主要企業簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2022-2024年營收年比比較

主要企業簡介

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • BGI Group
  • Qiagen
  • Quidel Corporation
  • Mylab Discovery Solutions
  • SD Biosensor
  • BioMerieux SA
  • Danaher Corporation
  • Hologic Inc.
  • Seegene Inc.
  • PerkinElmer Inc.
  • Randox Laboratories
  • CEPI(Collaborative entities)
  • Guangzhou Wondfo Biotech
  • Shenzhen Bioeasy Biotechnology
  • Cepheid Inc.
  • 1drop Inc.
  • ADT Biotech

結論與建議

簡介目錄
Product Code: SQMIG35J2168

Global COVID Testing Kit Market size was valued at USD 80.1 billion in 2023 and is poised to grow from USD 86.19 billion in 2024 to USD 154.86 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The global COVID testing kit market is witnessing a transformation driven by digital health solutions and the rise in e-commerce, particularly in urban areas where self-test kits are gaining popularity for their convenience. Nasal swab and saliva tests are favored for their ease of use. Industry players are focusing on multiplex diagnostics that can detect multiple respiratory viruses, which are increasingly sought by health authorities due to their cost-effectiveness. Furthermore, the integration of AI technology enhances testing accuracy and reduces turnaround times, bolstering consumer confidence in both home and lab testing. Despite facing challenges such as market saturation and cost pressures, the demand for COVID testing kits remains robust, signaling strong growth potential as innovations in mobile healthcare and diagnostics continue to develop.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global COVID Testing Kit market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global COVID Testing Kit Market Segments Analysis

Global COVID Testing Kit Market is segmented by Product Type, Specimen / Sample Type, End-User, Mode of Testing and region. Based on Product Type, the market is segmented into RT-PCR Assay Kits, Immunoassay Test Strips / Cassettes, CRISPR-Based Molecular Kits and Other Molecular Kits. Based on Specimen / Sample Type, the market is segmented into Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Saliva Sample and Blood / Finger-Prick. Based on End-User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care / Self-Testing, Public Health Agencies and Others. Based on Mode of Testing, the market is segmented into Centralized Lab Testing (Non-POC), Point-of-Care (POC) Testing and Over-The-Counter (OTC) Self-Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global COVID Testing Kit Market

One of the key market drivers for the Global COVID Testing Kit Market is the increasing demand for rapid and accurate diagnostic tools as the world continues to navigate through the pandemic and its variants. Growing awareness of the importance of early detection in managing outbreaks has propelled healthcare providers, governments, and individuals to prioritize testing. The rise in home testing kits offers convenience and accessibility, catering to a broader population. Additionally, continuous advancements in testing technology, including the development of highly sensitive and specific assays, further enhance the market's growth, addressing the diverse needs of healthcare systems globally.

Restraints in the Global COVID Testing Kit Market

The global COVID testing kit market faces significant restraints due to regulatory challenges and varying standards across different regions. The approval processes for testing kits can be lengthy and complex, leading to delays in product availability. Additionally, disparities in quality control and accuracy standards can undermine public confidence in testing solutions, hampering widespread adoption. These factors are compounded by the emergence of alternative diagnostic methods and shifting governmental priorities, which may divert funding and focus away from testing initiatives. Consequently, manufacturers must navigate a complicated landscape of compliance and market acceptance, impacting their growth potential.

Market Trends of the Global COVID Testing Kit Market

The Global COVID Testing Kit market is witnessing a significant shift towards self-testing and home diagnostics, spurred by a growing demand for decentralized healthcare solutions. As regulatory approvals expand, self-administered saliva-based antigen kits are gaining popularity among consumers due to their ease of use, affordability, and reduced clinic interaction, particularly during resurgences of infections. This trend reflects a broader consumer preference for convenience and autonomy in health management, significantly influencing market dynamics and encouraging innovations in product development. The emphasis on rapid, reliable testing options is reshaping the landscape of COVID testing, reinforcing the market's resilience and adaptability.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Assessment
  • Regulatory Landscape
  • Customer & Buying Criteria Analysis
  • Raw Material Analysis

Global COVID Testing Kit Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • RT-PCR Assay Kits
  • Immunoassay Test Strips / Cassettes
  • CRISPR-Based Molecular Kits
  • Other Molecular Kits

Global COVID Testing Kit Market Size by Specimen / Sample Type & CAGR (2025-2032)

  • Market Overview
  • Nasopharyngeal Swab
  • Oropharyngeal Swab
  • Nasal Swab
  • Saliva Sample
  • Blood / Finger-Prick

Global COVID Testing Kit Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care / Self-Testing
  • Public Health Agencies
  • Others

Global COVID Testing Kit Market Size by Mode of Testing & CAGR (2025-2032)

  • Market Overview
  • Centralized Lab Testing (Non-POC)
  • Point-of-Care (POC) Testing
  • Over-The-Counter (OTC) Self-Testing

Global COVID Testing Kit Market Size & CAGR (2025-2032)

  • North America (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
    • US
    • Canada
  • Europe (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quidel Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylab Discovery Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SD Biosensor
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMerieux SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Seegene Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CEPI (Collaborative entities)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Guangzhou Wondfo Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shenzhen Bioeasy Biotechnology
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cepheid Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 1drop Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ADT Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations